As a crucial hub of adipose inflammation and thermogenic gene induction, the NOD-RIPK2 pathway in brown adipocytes would be an attractive therapeutic target against obesity-associated diseases. The gene discussed is RIPK2; the disease is obesity due to melanocortin 4 receptor deficiency.